Oncolytics Biotech (ONCY) Posts Wider Q4 Loss
Tweet
Share
E-mailOncolytics Biotech (NASDAQ: ONCY) reported Q4 EPS of ($0.49), $0.39 worse than the analyst estimate of ($0.10).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Six Flags names Mark Pauls as chief operating officer
- Freedom Broker Starts Unity Bancorp (UNTY) at Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
